1st ALS Patient Enters Phase 3 Study of Oral Edaravone in Slowing Disability November 27, 2019 1st ALS Patient Enters Phase 3 Study of Oral Edaravone in Slowing DisabilitySource: ALS News TodayPublished on 2019-11-27By Marta Figueiredo
